Clinical Trial Update: Safety of KN057 Prophylaxis in Patients With Haemophilia A or B [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on the safety of KN057 prophylaxis in adults with hemophilia A or B; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• KN057

Snippet

Sponsor: Suzhou Alphamab Co., Ltd. | Conditions: Hemophilia A or B | Phase 3 | Status: RECRUITING